Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.
Sixteen patients with stable chronic asthma participated in a double blind crossover study comparing the new inhaled long acting beta 2 agonist formoterol with salbutamol. Inhaled (n = 15) and oral steroid (n = 1) treatment were maintained at the same daily dose throughout the study. For four weeks...
Saved in:
| Published in: | Thorax |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BMJ Publishing Group
1990
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC473768/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1972599/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.45.4.259 |
| Tags: |
No Tags, Be the first to tag this record!
|